Skip to Content

Join the 'TAC 3' group to help and get support from people like you.

TAC 3 Support Group

Further Information

TAC 3 Patient Information at

Latest News

Imbruvica Approval Expanded to Include Graft Versus Host Disease

WEDNESDAY, Aug. 2, 2017 – The U.S. Food and Drug Administration on Wednesday expanded approval for the anti-cancer drug Imbruvica (ibrutinib) to include adults with chronic graft versus host disease ...

Read more news...

Ask a Question